Dipna Pharmachem Ltd
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹770.55 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- ₹894.44 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Dipna Pharmachem Ltd had its IPO on under the ticker symbol DPL.
The company operates in the sector and industry. Dipna Pharmachem Ltd has a staff strength of 0 employees.
Shares of Dipna Pharmachem Ltd opened at ₹25.8 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹24.1 - ₹25.8, and closed at ₹25.
This is a -90.82% slip from the previous day's closing price.
A total volume of 30,000 shares were traded at the close of the day’s session.
In the last one week, shares of Dipna Pharmachem Ltd have slipped by -90.37%.
Dipna Pharmachem Ltd's Key Ratios
Dipna Pharmachem Ltd has a market cap of ₹770.55 million, indicating a price to book ratio of 0.3638 and a price to sales ratio of 3.7519.
In the last 12-months Dipna Pharmachem Ltd’s revenue was ₹0 with a gross profit of ₹894.44 million and an EBITDA of ₹0. The EBITDA ratio measures Dipna Pharmachem Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Dipna Pharmachem Ltd’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q3.6666666666667, Dipna Pharmachem Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Dipna Pharmachem Ltd’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dipna Pharmachem Ltd’s profitability.
Dipna Pharmachem Ltd stock is trading at a EV to sales ratio of 2.7097 and a EV to EBITDA ratio of 0.8122. Its price to sales ratio in the trailing 12-months stood at 3.7519.
Dipna Pharmachem Ltd stock pays annual dividends of ₹0.5 per share, indicating a yield of 2.51% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- Total Liabilities
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Dipna Pharmachem Ltd ended 2023 with ₹0 in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹0 while shareholder equity stood at ₹0.
Dipna Pharmachem Ltd ended 2023 with ₹0 in deferred long-term liabilities, ₹0 in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Dipna Pharmachem Ltd’s total current assets stands at ₹0 while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.
In 2023, Dipna Pharmachem Ltd's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Dipna Pharmachem Ltd paid ₹0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Dipna Pharmachem Ltd stock is currently trading at ₹25 per share. It touched a 52-week high of ₹298.35 and a 52-week low of ₹298.35. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹102.95 and 200-day moving average was ₹115.85 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.